Other OTC - Delayed Quote USD

Regenicin, Inc. (RGIN)

0.0050 0.0000 (0.00%)
At close: April 11 at 10:16 AM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Randall E. McCoy Chairman, CEO & President 250k -- 1949
Mr. John J. Weber CFO & Director 125k -- 1950
Dr. J. Roy Nelson Ph.D. Controller & Chief Science Officer 150k -- 1948

Regenicin, Inc.

10 High Court
Little Falls, NJ 07424
United States
973 557 8914 https://www.regenicin.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
3

Description

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

Corporate Governance

Regenicin, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers

RSPI RespireRx Pharmaceuticals Inc.
0.0008
-11.11%
 
TRML Tourmaline Bio, Inc.
15.66
-6.12%
 
TVTX Travere Therapeutics, Inc.
5.80
-3.17%
 
IMMP Immutep Limited
2.2000
-2.65%
 
ENZC Enzolytics, Inc.
0.0049
-6.54%
 
ADMA ADMA Biologics, Inc.
6.20
+2.65%
 
CYDY CytoDyn Inc.
0.1509
+3.32%
 
SAVAW Cassava Sciences, Inc.
0.6200
-12.68%
 
SAVA Cassava Sciences, Inc.
21.19
-0.38%
 
NVAX Novavax, Inc.
3.8900
0.00%